Table 3.

Pediatric sinonasal symptom survey (SN‐5)

SN‐5 components, median (IQR)	Conventional dosing n = 18	Genotype‐guided dosing n = 16	P value (unadjusted)	P valuea
Sinus infection	2.0 (1.0–3.0)	1.0 (1.0–2.5)	0.201	0.721
Nasal obstruction	2.5 (1.0–4.0)	1.0 (1.0–2.5)	0.170	0.327
Allergy symptoms	3.0 (2.0–4.0)	1.0 (1.0–2.0)	0.007	0.006
Emotional distress	2.5 (1.0–5.0)	1.5 (1.0–3.0)	0.198	0.528
Activity limitations	1.0 (1.0–3.0)	1.0 (1.0–1.0)	0.092	0.244
SN‐5 score	2.6 (2.0–3.4)	1.8 (1.0–2.3)	0.012	0.031

IQR, interquartile range.

^aAdjusted for baseline score, race, baseline proton pump inhibitor use, baseline histamine receptor antagonist use.